Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Medicago Inc MDCGF

GREY:MDCGF - Post Discussion

Medicago Inc > Phase II Interim Results
View:
Post by alexl1 on Jan 28, 2011 1:27pm

Phase II Interim Results

Hi everyone,

I e-mailed IR at MDG this morning with the following question?

"Good afternoon, would you be able to tell me if the interim results of the H5N1 Phase II trials will be presented at the end of this month being the end of this month is next Monday?

 

Re-iterating from what MDG stated in a recent news release “The Company expects to present interim Phase II clinical trial results with its H5N1 pandemic influenza vaccine in January, 2011”

 
This is the response I just recieved from MDG,

"Thanks for your interest in Medicago. Yes, we are on track to report our interim phase II results early next week. "

Maybe some excitement next week?

All, have a great weekend.

Be the first to comment on this post
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities